Announcements Trials

Browse Landscape

Phase

Phase 2 51 Phase 1 37 Phase 1/2 23 Phase 3 21 Phase 2/3 5 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Extranodal NK-T-Cell 2 Biliary Tract Neoplasms 2 Thoracic Neoplasms 1 Squamous Non-small-cell Lung Cancer 1 Oligospermia 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Lung Diseases 1 Fibrosis 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

Zoledronic Acid 5 Bevacizumab 3 exemestane 2 Therapeutics 2 Standard of Care 2 Pamidronate 2 Oxaliplatin 2 Misoprostol 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ibandronic Acid 2 Fulvestrant 2 Fluorouracil 2 Cetuximab 2 Capecitabine 2 vandetanib 1 palbociclib 1 liposomal doxorubicin 1 huaier 1 eribulin 1 enzalutamide 1 darolutamide 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Vindesine 1 Trastuzumab 1 Sugars 1 Stents 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasm Metastasis × Gemcitabine × Clear all

NCT06820255 2025-02-11

SELECTIO-UC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡